Quantcast

Latest Nile Stories

2010-12-03 16:00:00

SAN MATEO, Calif., Dec. 3, 2010 /PRNewswire/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced that, as anticipated, on November 30, 2010, the Company received a letter from the Listing Qualifications Staff (the "Staff") of The NASDAQ Stock Market (the "Staff Determination") notifying the Company that, based on its failure to regain compliance with the $1.00 minimum bid price requirement, as set...

2010-11-16 06:00:00

SAN MATEO, Calif., Nov. 16, 2010 /PRNewswire/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced that Joshua Kazam, Chief Executive Officer, will present at the Maxim Group Growth Conference on Thursday, November 18, 2010 at 10:30 a.m. EST at the Grand Hyatt Hotel in New York City, New York. The presentation will be webcast live and can be accessed by visiting the Investor Relations section of...

2010-11-12 07:00:00

SAN MATEO, Calif., Nov. 12, 2010 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for therapeutics for cardiovascular disease, today announced its third quarter financial results for 2010. Financial Results For the three months ended September 30, 2010, Nile reported a net loss of approximately $1.8 million, or $0.05 per share, compared to a net loss of approximately $2.0 million, or $0.08 per share, during the...

2010-10-07 15:37:00

SAN MATEO, Calif., Oct. 7 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that Michael R. Bristow, M.D. Ph.D. has joined the Scientific Advisory Board overseeing the development of CD-NP, a dual natriuretic peptide receptor agonist in development for the treatment of acute decompensated heart failure. Dr. Bristow, a recognized leader in the heart...

2010-09-30 09:00:00

SAN MATEO, Calif., Sept. 30 /PRNewswire/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced that Daron Evans, Chief Financial Officer, will present at the 9th Annual BIO Investor Forum Wednesday, October 6, 2010 at 8:30 a.m. (Pacific Time) at the Palace Hotel in San Francisco, California. About Nile Therapeutics Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops...

2010-09-09 06:13:00

SAN MATEO, Calif., Sept. 9 /PRNewswire/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced that Joshua Kazam, Chief Executive Officer, will present at the Rodman & Renshaw 12th Annual Global Investment Conference on Tuesday, September 14, 2010 at 2:00 p.m. (Eastern Time) at the Palace Hotel in New York City, New York. About Nile Therapeutics Nile Therapeutics, Inc. is a clinical-stage...

2010-08-16 06:30:00

SAN MATEO, Calif., Aug. 16 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced its second quarter financial results for 2010. Financial Results For the three months ended June 30, 2010, Nile reported a net loss of approximately $1.5 million, or $0.05 per share, compared to a net loss of approximately $2.5 million, or $0.10 per share, during the second quarter of 2009....

2010-07-22 06:30:00

SAN FRANCISCO, July 22 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced the appointment of Richard B. Brewer as Executive Chairman. With over 35 years of biotech and pharmaceutical industry experience, Mr. Brewer brings a wealth of operational, financial, and business development expertise to Nile. "We are extremely pleased to welcome Mr. Brewer to our...

2010-07-07 06:30:00

SAN FRANCISCO, July 7 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF. The study was designed to provide additional information on the safety and...

2010-06-04 07:00:00

SAN MATEO, Calif., June 4 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced that, on June 1, 2010, the Company received a letter from The Nasdaq Stock Market indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, Nile was not in compliance with Marketplace Rule 5550(a)(2). The Company has been...


Latest Nile Reference Libraries

Sir Samuel White Baker
2014-01-02 13:16:30

Sir Samuel White Baker, KCB, FRGS, FRS, born on June 8th of 1821 and died on December 30th of 1893, was a British explorer, naturalist, big game hunter, officer, engineer, writer, and abolitionist. He held the titles of Pasha and Major-General in the Ottoman Empire and Egypt as well. He served as the Governor-General of the Equatorial Nile Basin between April of 1869 and August of 1873, which he established as the Province of Equatoria. He is mainly remembered as the discoverer of Lake...

Nile Puffer, Tetraodon lineatus
2013-02-18 09:52:03

Image Credit: Earedien/Wikipedia The Nile puffer is also known as the fahaka pufferfish, globe fish, or lineatus puffer. It is a tropical freshwater puffer found in the river basins of Africa, mainly in the Nile and surrounding rivers. The fish will live in weed beds, and in any other vegetation-rich habitat. It can also be found in open water. If kept as a pet it is best to keep it solitary. The Nile puffer is territorial and aggressive toward other fish. Even young Nile puffer will...

Marbled Lungfish, Protopterus Aethiopicus
2012-12-25 12:06:57

The marbled lungfish is found mainly in the Nile river, in the northeastern continent of Africa. It also is found in such lakes as the Albert, Edward, Tanganyika, Victoria, Nabugabo, No and Kyoga, all centrally located in Africa at the southern end of the Nile. They live in the shallow areas of these lakes, streams, rivers, and swamps. During the dry season, many of the areas will dry up and when this occurs the marbled lungfish will bury themselves in the mud leaving just a small opening...

Nile Lechwe, Kobus megaceros
2012-09-10 17:01:29

The Nile lechwe (Kobus megaceros), a species of antelope, is also known as Mrs Gray's lechwe, the waterbuck, or the wasserbock. It can be found in Ethiopia and Sudan, where it prefers a habitat within grasslands, steppes, wetlands, coastal areas, or swamplands with water reaching a depth between 3.9 and 16 inches. Leopold Fitzinger first described this antelope in 1855. The Nile lechwe varies in size depending on sex, with males typically reaching a weight of up to 260 pounds and females...

agaf_001_php
2012-06-19 04:35:28

Symbol: AGAF Group: Monocot Family: Liliaceae Synonyms:   AGUM Agapanthus umbellatus L'Her. Classification:       Kingdom   Plantae – Plants Subkingdom   Tracheobionta – Vascular plants Superdivision   Spermatophyta – Seed plants Division   Magnoliophyta – Flowering plants Class   Liliopsida – Monocotyledons Subclass   Liliidae Order   Liliales Family   Liliaceae –...

More Articles (9 articles) »
Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.